Kenneth Kalunian

Other News

News Update
Breaking News

Obinutuzumab Showed Significantly Positive Results in Published Phase III Lupus Nephritis Study

February 7, 2025
Exciting breaking news: A paper published in the highly prestigious journal New England Journal of Medicine and presented at...
News Update

Adicet Bio Receives FDA Fast-Track Designation for Investigational SLE Therapy

February 5, 2025
Lupus Therapeutics shares news that Adicet Bio received Fast Track Designation from the U.S. Food and Drug Administration for...
News Update

On “Endpoints Clinical Trials Day,” Lupus Therapeutics EVP  Expresses Optimism About the Current State of Lupus Research

December 17, 2024
Today is “Endpoints Clinical Trials Day,” hosted by international biopharma news outlet Endpoints News. The day features a series...